Evidence map›Paper›PMID 42699463›Full record

ArticleInternational journal of surgery case reports2026

Controlled hypotension therapy with isosorbide dinitrate for postoperative bleeding of transurethral resection of the prostate.

Zihao Li, Hongliang Li, Zhenzhuo Chen, Li Wang, Tie Chong, Dong Zhang

Abstract read
In one paragraph

Article in International journal of surgery case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zihao LiMedical Department, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Hongliang LiDepartment of Urology Surgery, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Zhenzhuo ChenMedical Department, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Li WangDepartment of Urology Surgery, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Tie ChongDepartment of Urology Surgery, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Dong ZhangDepartment of Urology Surgery, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Postoperative bleeding is a well-known complication of transurethral resection of the prostate (TURP). This study aims to evaluate the efficacy and safety of controlled hypotension using isosorbide dinitrate (ISDN) as a treatment for refractory postoperative bleeding after TURP when conventional non-surgical treatments have failed. Methods: A retrospective analysis was conducted of eight patients who experienced postoperative bleeding following TURP and did not respond to standard non-surgical interventions. Patients were treated with an intravenous infusion of ISDN to induce controlled hypotension. The hemostatic effect was subsequently observed and evaluated once the mean arterial pressure was lowered to a target range of 66-73 mmHg. Outcomes: Hemostasis was achieved rapidly in all eight patients following the induction of controlled hypotension. The treatment demonstrated a highly satisfactory clinical effect, and no severe adverse events or complications were observed during or after the intervention. Conclusion: Controlled hypotension via intravenous ISDN is a safe, rapidly effective, and promising therapeutic alternative for managing refractory postoperative bleeding after TURP when conventional non-surgical measures fail.

Indexed as

case seriescontrolledhypotensionisosorbide dinitratetransurethral resection of the prostate

Identifiers

PMID42699463
PMCPMC13544727

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.